Penn Medicine Provider
Renal Electrolyte and Hypertension
Abdallah Geara, MD
4.9
(505)
Accepting new patients
Sees patients age 18 and up
Penn Renal Electrolyte and Hypertension Perelman
View 1 additional location

About me

  • Clinical Director of the Glomerular Disease Program
  • Director of Onconephrology
  • Associate Professor of Clinical Medicine (Renal-Electrolyte and Hypertension)

Education and training

  • null
  • Residency: Lebanese University
  • Residency: Staten Island University Hospital (North Site)
  • Fellowship: NewYork-Presbyterian/Columbia University Medical Center

What my patients think about me

Average Rating
4.9

507 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
excellent service
May 2025
5.0
5.0
patient and caring
April 2025
5.0
5.0
he makes you feel very comfortable. and answers any questions that you have.
April 2025
5.0
5.0
dr. geara listens intently to everything i said about myself since i saw him 6 months ago. he conducted an intelligent and clear conversation about what he plans based on my blood/urine test results.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Geara is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

My research

Gupta S, Kaunfer SA, Chen KL, Dias JA, Vijayan A, Rajasekaran A, Prosek J, Truong HL, Wood A, Bassil C, Renaghan AD, Shah CV, Zhang J, Glezerman I, Carlos C, Kelly K, Passero CJ, Drappatz J, Abudayyeh A, Shin D, Sperati CJ, Yelvington BJ, Kanduri SR, Neyra JA, Edmonston D, Shirali AC, Bansal A, Geara A, Mithani Z, Ziolkowski SL, Rashidi A, Jakubowski J, Pujari A, Bond DA, Dotson EK, Wall SA, Patton JT, Barreto JN, Hermann SM, Sheikh MS, Baz RC, Lee JH, Lucchesi N, Kolman M, Rasheed MA, Afzal A, Kang D, Mahesh A, Hsu R, Nicolaysen A, Tefera K, Schretlen C, Miller RM, Velez JCQ, Flannery AH, Aklilu AM, Anand S, Chandrasekhara S, Donley V, Patel A, Ni J, Krishnamurthy S, Ali R, Yilmam OA, Wells SL, Ortega JL, Green-Lingren OL, Leaf RK, Sise ME, Nayak L, LaCasce AS, Leung N, Leaf DE. "Glucarpidase for Treatment of High-Dose Methotrexate Toxicity" , Blood: 2025


Keith W Hamilton 1, Elvis Hua 2, Lauren Dutcher 1, Holly Fernandez Lynch 3, Paul Junker 4, Abigail G Doucette 5, Danielle Werner 6, Ethan Z Kannel 7, Thomas Civitello 7, Peter Gabriel 5, Vivek N Ahya 6 8, Dina A Jacobs 9, Alfred Garfall 10, Keith Pratz 10, Kathleen O Degnan 1, Emily A Blumberg 1, Donna Capozzi 11, Ethan Craig 12 13, Patricia Takach 14, Aimee S Payne 15, Abdallah Geara 16, Helen Koenig 1, Lawrence Holzman 16, Pablo Tebas 1 Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience From a Single Medical Center , Open Forum Infectious Disease: 2024


Reza Zonozi, MD, Faten Aqeel, MD, Dustin Le, MD, Frank B. Cortazar, MD, Jugal, Thaker, MD, Maria Jose Zabala Ramirez, MD, Sebastian Eduardo Sattui Cortes, MD, Rose Mary Attieh, MD, Madeline Chung, MD, David H. Bulbin, DO, Aisha Shaikh, MD, Karina Guaman, BA, Julia Ford, MD, Colin Diffie, MD, Ora Gewurz-Singer, MD, Gabriel Sauvage, BS, Anushya Jeyabalan, MD, Abdallah Geara, MD, Isabelle Ayoub, MD, Andrew Bomback, MD, Lara L. Khoury, MD, Jason C. George, DO, Kenar D., Jhaveri, MD, Vimal Kumar Derebail, MD, John L. Niles, MD, Duvuru Geetha, MD "Real-world experience with avacopan in ANCA-associated vasculitis" , Kidney International Reports: 2024


Michelle N Rheault 1, Charles E Alpers 1, Jonathan Barratt 1, Stewart Bieler 1, Pietro Canetta 1, Dong-Wan Chae 1, Gaia Coppock 1, Ulysses Diva 1, Loreto Gesualdo 1, Hiddo J L Heerspink 1, Jula K Inrig 1, Gianna M Kirsztajn 1, Donald Kohan 1, Radko Komers 1, Laura A Kooienga 1, Kenneth Lieberman 1, Alex Mercer 1, Irene L Noronha 1, Vlado Perkovic 1, Jai Radhakrishnan 1, William Rote 1, Brad Rovin 1, Vladimir Tesar 1, Hernán Trimarchi 1, James Tumlin 1, Muh Geot Wong 1, Howard Trachtman 1; DUPRO Steering Committee and DUPLEX Investigators "Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis" , NEJM: 2023


Rovin, B, et al "Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial" , Lancet: 2023


Hiddo J L Heerspink 1, Jai Radhakrishnan 2, Charles E Alpers 3, Jonathan Barratt 4, Stewart Bieler 5, Ulysses Diva 6, Jula Inrig 6, Radko Komers 6, Alex Mercer 7, Irene L Noronha 8, Michelle N Rheault 9, William Rote 6, Brad Rovin 10, Howard Trachtman 11, Hernán Trimarchi 12, Muh Geot Wong 13, Vlado Perkovic 14; PROTECT Investigators "Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial" , Lancet: 2023


Vinay Srinivasan, Bader Kfoury, Sarah Ahmad, Jordana Cohen, and Abdallah S Geara Long term outcomes of bevacizumab-associated kidney adverse effects , Journal of Onco-Nephrology: 2022


Amudala NA, Boukhlal S, Sheridan B, Langford CA, Geara A, Merkel PA, Cornec D. "Obinutuzumab as Treatment for ANCA-Associated Vasculitis" , Rheumatology (Oxford).: 2021


Srinivasan V, Geara AS, Han S, Hogan JJ, Coppock G. "Need for symptom monitoring in IgA nephropathy patients post COVID-19 vaccination" , Clin Nephrol: 2021


Liann Abu Salman, Christos Kallis, Matthew Palmer, Jehan Bahrainwala, Abdallah S Geara "New-Onset Proteinuria in a Patient With Schwannoma" , American Journal Of Kidney Disease: 2021